Theriva Biologics, Inc. Proceeds from (Repurchase of) Equity
Theriva Biologics, Inc. (TOVX) reported Proceeds from (Repurchase of) Equity of $3.00 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-20.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepurchaseOfEquity · last filed 2021-03-04
- Theriva Biologics, Inc. proceeds from (repurchase of) equity for fiscal 2019 was $3.00M, a 0.00% change from fiscal 2018.
- Theriva Biologics, Inc. proceeds from (repurchase of) equity for fiscal 2018 was $3.00M, a 0.00% change from fiscal 2017.
- Theriva Biologics, Inc. proceeds from (repurchase of) equity for fiscal 2017 was $3.00M, a 0.00% change from fiscal 2016.
- Theriva Biologics, Inc. proceeds from (repurchase of) equity for fiscal 2016 was $3.00M, a 0.00% change from fiscal 2015.
| Period end | Proceeds from (Repurchase of) Equity | Proceeds from (Repurchase of) Equity 12 month |
|---|---|---|
| 2019-12-31 | $3.00M 10-K · filed 2020-02-20 | |
| 2018-12-31 | $3.00M 10-K · filed 2019-02-27 | |
| 2018-09-05 | $3.00M 10-K · filed 2020-02-20 | |
| 2017-12-31 | $3.00M 10-K · filed 2019-02-27 | |
| 2016-12-31 | $3.00M 10-K · filed 2018-02-22 | |
| 2015-12-31 | $3.00M 10-K · filed 2016-03-10 | |
| 2014-12-31 | $3.00M 10-K · filed 2015-03-16 | |
| 2013-12-31 | $3.00M 10-K · filed 2014-03-31 | |
| 2013-12-05 | $3.00M 10-K · filed 2021-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |